Platelet α–granules: Basic biology and clinical correlates
By Price S. Blair, R. Flaumenhaft. Blood reviews, 2009
1,139 citations recorded by the source corpus.
Summary α–Granules are essential to normal platelet activity. These unusual secretory granules derive their cargo from both regulated secretory and endocytotic pathways in megakaryocytes. Rare, inheritable defects of α–granule formation in mice and man have enabled identification of proteins that mediate cargo trafficking and α–granule formation. In platelets, α–granules fuse with the plasma membrane upon activation, releasing their cargo and increasing platelet surface area. The mechanisms that control α–granule membrane fusion have begun to be elucidated at the molecular level. SNAREs and SNARE accessory proteins that control α–granule secretion have been identified. Proteomic studies demonstrate that hundreds of bioactive proteins are released from α–granules. This breadth of proteins implies a versatile functionality. While initially known primarily for their participation in thrombosis and hemostasis, the role of α–granules in inflammation, atherosclerosis, antimicrobial host defense, wound healing, angiogenesis, and malignancy has become increasingly appreciated as the function of platelets in the pathophysiology of these processes has been defined. This review will consider the formation, release, and physiologic roles of α–granules with special emphasis on work performed over the last decade.
Subfields: Cancer Research, Hematology, Immunology and Allergy
View Paper: https://www.semanticscholar.org/paper/f4320211d2208231e5267654fb936d83e0c33ce7
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Hematology
Citations in the corpus
- Platelets, inflammation and tissue regeneration (2011, neutral): “This involves (i) increased expression of urokinase-type plasminogen activator receptor and MTI-MMP, (ii) secretion of urokinase-type plasminogen activator, tissue-type plasminogen activator and MMP-1, with (iii) induced proteolytic activity via MMP-2 and MMP-9.”
- Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors (2013, background): “Some recent reviews discuss the existence of different α-granules [50-52].”
- Circulating Platelets as Mediators of Immunity, Inflammation and Thrombosis (2018, background): “In addition to PF4 and RANTES, platelet α-granules contain various antimicrobial compounds such as platelet CTAP-3 (connective tissue–activating peptide 3), platelet basic protein, Tβ-4 (thymosin β-4), and fibrinopeptide (A and B).(87,88) These platelet-derived antimicrobial compounds are known to t”
- Platelet secretion: From haemostasis to wound healing and beyond (2015, background): “the surface of the platelet following platelet activation, further amplifying platelet aggregation [31].”
- Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020 (2020, background): “The overall functions of these specific platelet granule constituents are to recruit and activate other immune cells or induce endothelial cell inflammation (Figure 2) [57].”
- The incredible journey: From megakaryocyte development to platelet formation (2013, background): “In MKs, granules are derived from budding of small vesicles containing granule cargo from the trans-Golgi network (Blair and Flaumenhaft, 2009).”